7 medicines held by BIAL-Portela & Ca, S.A. on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Ongentys 25 mg hard capsules EU/1/15/1066/001 |
Opicapone | BIAL-Portela & Ca, S.A. | — |
| Ongentys 50 mg hard capsules EU/1/15/1066/002-007 |
Opicapone | BIAL-Portela & Ca, S.A. | — |
| Zebinix 200 mg Tablet EU/1/09/514/021-023 |
Eslicarbazepine acetate | BIAL-Portela & Ca, S.A. | — |
| Zebinix 400 mg Tablet EU/1/09/514/1-6 |
Eslicarbazepine acetate | BIAL-Portela & Ca, S.A. | — |
| Zebinix 50 mg/ml Oral suspension EU/1/09/514/024 |
Eslicarbazepine acetate | BIAL-Portela & Ca, S.A. | — |
| Zebinix 600 mg Tablet EU/1/09/514/7-11 |
Eslicarbazepine acetate | BIAL-Portela & Ca, S.A. | — |
| Zebinix 800 mg Tablet EU/1/09/514/12-20 |
Eslicarbazepine acetate | BIAL-Portela & Ca, S.A. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.